BTAI 8-K 2026-08-25

BioXcel Therapeutics, Inc. (BTAI) 8-K dated 2026-08-25 — accession 0001104659-26-100532. This URL is the filing, not the BTAI hub.

BioXcel Therapeutics, Inc. (BTAI) is a drug manufacturers - specialty & generic company listed on US.

BioXcel Therapeutics, Inc. filed a 8-K on 2026-08-25. Accession 0001104659-26-100532.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.

Not investment advice. The BTAI SEC hub lists recent forms. The stock page is the research view.